Silence Therapeutics (SLN)
NASDAQ:SLN
Holding SLN?
Track your performance easily

Silence Therapeutics (SLN) Ownership - Who Owns Silence Therapeutics?

107 Followers

Silence Therapeutics (SLN) Ownership Overview

0.13%0.08%0.14%99.65%
0.08% Other Institutional Investors
0.14% ETFs
99.65% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail, and individual investors. Approximately 0.35% of the company’s stock is owned by Institutional Investors, and 99.65% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$1726378

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
387,400Institution0.83%7,004,192
90,862Institution0.19%1,642,785
52,132Institution0.11%942,547
34,893Institution0.07%630,865
22,427Institution0.05%405,480
8,077Institution0.02%146,032
4,674Institution0.01%84,506
4,238Institution<0.01%76,623

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
34,893Institution0.07%630,865
22,427Institution0.05%405,480
4,238Institution<0.01%76,623

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
52,132Institution0.11%936,812
8,077Institution0.02%145,144
4,674Institution0.01%84,506

FAQ

Who Owns Silence Therapeutics (SLN)?
Currently, no data Available
What percentage of Silence Therapeutics (SLN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.08% of Silence Therapeutics (SLN) stock is held by institutional investors.
    What percentage of Silence Therapeutics (SLN) stock is held by retail investors?
    According to the latest TipRanks data, approximately 99.65% of Silence Therapeutics (SLN) stock is held by retail investors.
      Who owns the most shares of Silence Therapeutics (SLN)?
      Stanley Druckenmiller owns the most shares of Silence Therapeutics (SLN).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis